Related Experiment Video
Updated: Oct 2, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Effect of cell fusion on metastatic ability of mouse hepatocarcinoma cell lines
Abstract:
AIM:To study the effect of cell fusion on metastatic ability of mouse hepatocarcinoma cells and the factors involved in the process of metastasis.METHODS: By the method of successively increasing the concentrations, cell fusion and limit dilution, 8-Ag resistant cells were selected, and HGPRT-Hca-P cells and eight cloned hybridoma cells were obtained. To observe their metastatic ability, they were inoculated into mice foodtaps and the drainage lymph nodes were examined under microscope.RESULTS:The end concentration of 8-Ag which was used to select HGPRT deficient Hca-P cells was 30mg/L.All the cells selected died in HAT culture medium in one week.Fused cells appeared approximately 9 days later. They were round, transparent and a little larger than their parental cells. Eight clones of hybridoma cells were obtained and named as PSH1-PSH8. The metastatic rate of HGPRT-Hca-P cells and PSH7 cells was 28.6% and 71.4% respectively, the difference being significant (P < 0.05). The metastatic rate of other clones was no more than 20% and there was no significant difference from HGPRT-Hca-P cells (P >0.05).CONCLUSION:In normal mice splenic lymphocytes, there are some factors that could inhibit tumor metastasis, however, there are some other factors accelerating tumor cells to metastasize. The establishment of PSH7 provides an experimental model which could be used to study the factors involved in metastasis.
Insights
Cell fusion altered the metastatic ability of mouse hepatocarcinoma cells. Hybridoma PSH7 significantly increased metastasis, suggesting factors in splenic lymphocytes can both inhibit and accelerate tumor spread.
Area of Science:
- Cancer Biology
- Cell Biology
- Immunology
Background:
- Understanding the mechanisms of tumor metastasis is crucial for developing effective cancer therapies.
- Investigating the role of cell fusion in altering cancer cell behavior offers insights into metastatic potential.
Purpose of the Study:
- To investigate the impact of cell fusion on the metastatic capabilities of mouse hepatocarcinoma cells.
- To identify factors within normal splenic lymphocytes that influence tumor metastasis.
Main Methods:
- Selection of 8-azaguanine (8-Ag) resistant hepatoma cells (HGPRT-Hca-P) using increasing concentrations.
- Cell fusion techniques to generate hybridoma cell lines.
- Inoculation of cells into mice and examination of lymph nodes to assess metastatic rates.
Main Results:
- Eight hybridoma clones (PSH1-PSH8) were successfully generated.
- Hybridoma clone PSH7 exhibited a significantly higher metastatic rate (71.4%) compared to parental HGPRT-Hca-P cells (28.6%) (P < 0.05).
- Other hybridoma clones showed metastatic rates comparable to parental cells (≤20%).
Conclusions:
- Normal mouse splenic lymphocytes contain factors that can both inhibit and promote tumor cell metastasis.
- The PSH7 hybridoma cell line serves as a valuable model for studying the complex factors involved in cancer metastasis.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

